BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.310
+0.030 (2.34%)
Jan 22, 2026, 4:00 PM EST - Market closed
BioCardia Market Cap
BioCardia has a market cap or net worth of $13.9 million as of January 23, 2026. Its market cap has increased by 31.28% in one year.
Market Cap
13.90M
Enterprise Value
9.25M
1-Year Change
31.28%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $13.90M, a decrease of -52.18%. That is a compound annual growth rate of -7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 13.58M | 2.40% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hoth Therapeutics | 15.59M |
| IO Biotech | 15.56M |
| Applied Therapeutics | 15.55M |
| Cellectar Biosciences | 15.07M |
| Cocrystal Pharma | 14.40M |
| Moleculin Biotech | 14.32M |
| Soligenix | 13.72M |
| NuCana | 13.23M |